3rd Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to H. R. 1628, The American Health Care Act and the Senate version, the Better Care Reconciliation Act, H. R. 2430, The FDA Reauthorization Act of 2017, and S. 934, the FDA Reauthorization Act of 2017.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 934 (115th), H.R. 1628 (115th), H.R. 2430 (115th)

Medicare/Medicaid MMM

Issues related to Medicaid CPI Penalty.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.

Foreign entity interest: Glenmark

LobbyistCovered position, as disclosed
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.